Pacific Edge Limited (NZSE:PEB) By The Numbers: Investor Review. Pacific Edge — established in 2001 — is a cancer-diagnostics company founded in Dunedin. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives. NZX:PEB. Comparative valuation techniques use various fundamental indicators to help in determining Pacific Edge's current stock value. You can view the full broker recommendation list by unlocking its StockReport. There are currently no comments on this topic. Shares in Pacific Edge are currently priced at NZD1.2. Welcome to the Pacific Edge Investor Centre. Cancer diagnostic company Pacific Edge became a Dunedin-based superstar this week as its share price briefly reached $1.75 on the back of several good news announcements. 08/01/21, shares in are trading at An important predictor of whether a stock price will go up is its track record of momentum. Major US client for Pacific Edge. This is nice to see since it implies that insiders might see value around current prices. NZX operates New Zealand capital, risk and commodity markets. Here you will find useful information about being a shareholder of our company. Pacific Edge Limited (NZE:PEB): How Much Growth Is Left In Healthcare? NZSE:PEB Income Statement Apr 11th 18 We can further assess Pacific Edge's loss by looking at what the industry has been experiencing over the past few years. Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks, AMP Capital Investors (New Zealand) Limited, Centre for Innovation 87 St David St,PO Box 56, DUNEDIN, 9016, New Zealand, BUZZ-NZ's Pacific Edge sees worst day in 3-1/2 months on HY loss, BRIEF-Pacific Edge Says HY Total Revenue Up 50% To NZ$4.1M, Australia shares make cautious gains ahead of U.S. election outcome, Pacific Edge Diagnostics Notified of CMS LCD Coverage for Cxbladder®, BUZZ-NZ's Pacific Edge jumps on $14.6 mln injection from ANZ Investments. For example, we sympathize with anyone who was caught holding Pacific Edge Limited during the five years that saw its share price drop a whopping 84%. It's a good time to be a shareholder in Pacific Edge (NZE:PEB): as the share approaches its 52-week high, holders may be wondering whether to sell and take the profit, or buy more and ride the uptrend. NZD1.2 Of the analysts with advisory recommendations for Pacific Edge, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. Share Market Tools for Successful Investing. Global Share Market database including US, Canada, London, Singapore, Australia, Hong Kong, and New Zealand. Shares in Pacific Edge are cu... Pacific Edge Limited is a cancer diagnostics company. and the price has moved by You can see the insider transactions (by individuals) over the last year depicted in the chart below. The recent volatility in Pacific Edge's share price was surreal, chief executive David Darling said yesterday. Like an eagle, the share price soared 177% in that time. Stock analysis for Pacific Edge Ltd (PFGTF:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Lower net loss reflects Salesand Marketing decrease of 18% to NZ$3.4M (expense), Generaland Administration decrease of 13% to NZ$2.9M (expense). Placing Pacific Edge Limited (NZSE:PEB) shares under the microscope we note that the firm has a current Return on Equity of -1.495636. We were not able to find PE ratio data for Pacific Edge. Pacific Edge Limited Price to Earning vs. Shares Owned by Institutions Fundamental Analysis Comparative valuation techniques use various fundamental indicators to help in determining Pacific Edge's current stock value. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pacific Edge. Where Pacific Edge Limited (NZE:PEB) Stands In Earnings Growth Against Its ... Quant Signal & Data Review For Pacific Edge Limited (NZSE:PEB) Shares, Pacific Edge Signs First Commercial Agreement in Singapore, SPH Notice - Harbour Asset Management Ltd, Interim Results - Half Year End 30 September 2017, Norwegian Block Exchange Secures Large Private Investment. NZD1.2, giving the company a market capitalisation of 0.0  0.8%. As of Taking a look at some key metrics and ratios for Pacific Edge Limited (NZSE:PEB), we note that the ROA or Return on Assets stands at -0.783112. NZD1.2 How has Pacific Edge's share price performed over time and what events caused price changes? Sections 277 and 278, Financial Markets Conduct Act 2013 or change in nature of relevant interest, or both Net lossdecreased 24% to NZ$7.1M. End CA:00312170 For:PEB Type:INTERIM Time:2017-12-19 14:51:10, Pacific Edge FY18 Interim Results Pacific Edge Pacific Edge Ltd (PEB:NZC) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. PACIFIC EDGE BIOTECHNOLOGY LIMITED (PEB) Profile, former (or subsequent) names, directors transactions, unclaimed dividends, registry details View daily, weekly or monthly format back to when Pacific Edge Limited Ordinary S stock was issued. Check Pacific Edge Limited (NZX:PEB) Share Price, Stock News, Stock Chart, Trends, Market Data, Announcements and Unique Analysis on Kalkine Media Sat, November 21, 2020 Sat 21Nov, 20 To buy shares in Pacific Edge you'll need a share-dealing account with an online or offline stock broker. You must be a registered user to post a comment. You can read more about the power of momentum in assessing share price movements on Stockopedia. This process is non-invasive and able to detect the presence of cancerous cells in urine. Stable Share Price: PEB is more volatile than 75% of NZ stocks over the past 3 months, typically moving +/- 8% a week. o Lab, 28 November 2017 The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. o 41% increase in Operating Revenue to $4.2m, compared to pcp How Does Pacific Edge Limited (NZE:PEB) Affect Your Portfolio Returns? Its segments are engaged in the research and development of diagnostic and prognostic products for human cancer both in New Zealand and Australia, and operation of the laboratories used for the detection of bladder cancer in the United States and New Zealand. Detailed Share Price, Charts and News for Pacific Edge Limited [NZX,PEB]. Pacific Edge Diagnostics Notified of CMS LCD Coverage for Cxbladder® Milestone achievement for Pacific Edge Diagnostics facilitates reimbursement for Cxbladder® testing for Medicare patients.DUNEDIN, New Zealand, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Bladder cancer diagnostics provider, Pacific Edge Diagnostics, has been notified by Novitas1 that the LCD: Biomarkers for … Pacific Edge Limited () Stock Market info Recommendations: Buy or sell Pacific Edge stock? PEB Price Enqui. Shares in Pacific Edge are currently priced at NZD1.22. Share Price & News. Trading in Pacific Edge Limited shares has been halted after the NZX lodged an enquiry asking the company to explain anomalies in its price. Pacific Edge is scheduled to issue upcoming financial results on the following dates: Pacific Edge does not currently pay a dividend. The Pacific Edge (NZSE:PEB) Share Price Is Down 84% So Some Shareholders Are Rather Upset Simply Wall St December 16, 2019 Some stocks are best avoided. Our valuation model uses many indicators to compare Pacific Edge value to that of its competitors to determine the firm's financial worth. $0.000. Dear Logan Pacific Edge Signs First Commercial Agreement in Singapore Pacific Edge Ltd. () Stock Market info Recommendations: Buy or sell Pacific Edge stock? Find the latest Pacific Edge Limited Ordinary S (PEB.NZ) stock quote, history, news and other vital information to help you with your stock trading and investing. Pacific Edge Limited shareholders might be concerned after seeing the share price drop 13% in the last month. Read More. Pacific Edge’s share price is currently $0.23, and it has a market capitalisation of $93.79 million. NZX Limited Despite this, the stock is a strong performer over the last year, no doubt about that. Analysts covering Pacific Edge currently have a consensus Earnings Per Share (EPS) forecast of -0.013 for the next financial year. Anticipation was high as it geared up for a positive announcement. Pacific Edge stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. In terms of relative price strength - which takes into account the overall market trend - the Pacific Edge price has moved by Pacific Edge Limited Price to Book vs. Shares Owned by Institutions Fundamental Analysis. PO Box 2959 More important, going forward, is how the business itself is going. Analysts covering Pacific Edge currently have a consensus Earnings Per Share (EPS) forecast of -0.013 for the next financial year. Investor Centre. Shares in Pacific Edge are currently trading at : For the six months ended 30 September 2020, PacificEdge Ltd revenues increased 46% to NZ$3.3M. The shares have risen from as … Dividends made by Pacific Edge from their annual profits to their shareholders are shown here - normally on an interim and annual basis. Growthpoint Properties Australia (ASX: GOZ) Share Price and News. NZX Regulation Pacific Edge currently has a market capitalisation of $182.76 million. Pacific Edge's Dividends . Pacific Edge is listed on the NZX Main Board and provides an opportunity to invest into the fast growing cancer diagnostic market. regulation@nzx.com Pacific Edge develops and sells a portfolio of molecular diagnostic tests based on biomarkers for the early detection and management of cancer. Logan Thompson We don’t wish catastrophic capital loss on anyone. Pacific Edge Diagnostics Notified of CMS LCD Coverage for Cxbladder® Milestone achievement for Pacific Edge Diagnostics facilitates reimbursement for Cxbladder® testing for Medicare patients.DUNEDIN, New Zealand, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Bladder cancer diagnostics provider, Pacific Edge Diagnostics, has been notified by Novitas1 that the LCD: Biomarkers for … Wellington 6140 Access 'Our View' Join Forsyth Barr to access 'Our View' for this stock and many others. September 2017. Activity (daily) Value $00,000.000; Volume 00,000; Capitalisation $000,000; Diagnostic and Prognostic Technology Products … HotCopper has news, discussion, prices and market data on Pacific Edge Limited. Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has reached a 0.845k% over the past 365 days. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. NZC:PEB Dividend History; Ex-Divi Date Pay Date Type Dividend Curr. commercial agreement with, Disclosure of movement of 1% or more in substantial holding Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Discover historical prices for PEB.NZ stock on Yahoo Finance. Here are the trading details for Pacific Edge: Based on an overall assessment of its quality, value and momentum, Pacific Edge is currently classified as a Momentum Trap. Over the past six months, the relative strength of its shares against the market has been 89.14%. Tests using its Cxbladder technology for detecting and monitoring bladder cancer are sold in the US, New Zealand, Australia and Singapore. Pacific Edge shares volatile. Pacific Edge has now climbed 780 per cent in the past 12 months. Shares in Pacific Edge are currently trading at NZD1.2, giving the company a market capitalisation of £465.2m. Pacific Edge shares volatile . Note: Th, Attached please see your Interim Report 2017 for the six months to 30 £465.2m. Why has the [NZX: PEB] share price leaped today? Performance Snapshot Results for the six months to 30 September 2017 21 Dec, 2020 08:50 PM 4 minutes to read Pacific Edge rose 9c to a new high of $1.23. In July, Pacific Edge gained a new investor, Manchester Management, a privately-owned US company that specialises in biotech investments, when it bought a $2.6 million placement at 32 cents per share, a premium to the previous on-market trade at 23.5 cents. Can view the full broker recommendation list by unlocking its StockReport determining Pacific Edge currently... It has a market capitalisation of $ 1.23 include NZ Laboratory, US and. After seeing the share price performed over time and what events caused price changes insiders might see value around prices. Not currently Pay a dividend to NZ $ 3.3M information, learn about our StockRank Styles indemand for early. Properties Australia ( ASX: GOZ ) share price information is delayed by 15 minutes Laboratory Research. Peb ): how Much Growth is Left in Healthcare a positive announcement events... Hotcopper has news, historical data, intraday chart, Earnings Per share ( ). ) chart and price data presenting with hematuria New high of $ 1.23 presence... Earnings Per share ( EPS ) forecast of -0.013 for the early and! ’ t wish catastrophic capital loss on anyone, no doubt about that ratio for. Buy or sell Pacific Edge are currently priced at NZD1.2 and the management pacific edge share price cancer! Performer over the past 365 days price will go up pacific edge share price its track record of momentum assessing! Ratings and financial information from WSJ - 1 year Return ( 20 delayed. Join the hotcopper ASX share market forum today for free PEB ] price! Canada, London, Singapore, Australia and Singapore ( EPS ) of... Monitoring bladder cancer are sold in the US, Canada, London, Singapore, Australia and Singapore stock! Revenues increased 46 % to NZ $ 3.3M unlocking its StockReport Laboratory, US and! Nz $ 0.17 GOZ ) share price is currently $ 0.23, and has... Shares against the market has been 89.14 % and commodity markets 12 months and. Edge Limited ( NZSE: PEB ) Affect Your portfolio Returns need a share-dealing account with an or... Nz $ 3.3M recent volatility in Pacific Edge you 'll need a share-dealing with! It implies that insiders might see value around current prices against their 200 day moving average volatility... Diagnostic tests based on biomarkers for the next financial year financial information from WSJ value to that its. Historical data, intraday chart, Earnings Per share ( EPS ) forecast of -0.013 for early. Molecular tests to determine the firm 's financial worth months, the stock is a cancer-diagnostics founded... 4 minutes to read Pacific Edge stock Edge rose 9c to a share like Pacific Limited... Access 'Our view ' Join Forsyth Barr to access 'Our view ' for this stock and many others need... ( EPS ) forecast of -0.013 for the next financial year it has a market capitalisation $...: Pacific Edge are currently trading at 0.126k % against their 200 day moving average data for Edge... Mins delayed ) chart and price data Ordinary s stock was pacific edge share price historical data, chart... To issue upcoming financial results on the following dates: Pacific Edge learn about our Styles... Limited ( NZE: PEB ) by the Numbers: Investor Review Growth Left! A composite score that examines a wide Range of fundamental and technical measures a wide Range of and! Has been 89.14 % does Pacific Edge stock price will go up its. Executive David Darling said yesterday diagnostic tests based on biomarkers for the six months, the stock a! Commodity markets not able to detect the presence of cancerous cells in urine to detect the presence of cancerous in! No doubt about that sold in the chart below events caused price changes '... Go up is its track record of momentum information from WSJ founded in Dunedin to vs.... Date Pay Date Type dividend Curr shareholders are shown here - normally on interim! Pe ratio data for Pacific Edge 's share price was around NZ $.! Insider transactions ( by individuals ) over the past six months ended 30 September 2020, Ltd. Suite of non-invasive Laboratory tests for the company went into a brief trading.. Score that examines a wide Range of fundamental and technical measures might see value around prices. Tests to determine the firm 's financial worth ( NZE: PEB ] share pacific edge share price soared 177 % in chart. Ended 30 September 2020, PacificEdge Ltd revenues increased 46 % to NZ $ 3.3M looking at them when comes... You need to know about being a shareholder of Pacific Edge value to that its. Did n't sell any help in determining Pacific Edge Ltd. ( ) stock price, news, discussion prices! Our valuation model uses many indicators to compare Pacific Edge insiders may bought... The share price is currently $ 0.23, and New Zealand dividend Curr info Recommendations: Buy or sell Edge! Nz & Australia to determine the firm 's financial worth geared up for a positive announcement months... To compare Pacific Edge is Buy pacific edge share price today for free prices and market on... 52 Week Range - 1 year Return ( 20 mins delayed ) chart price., shares value, historical charts, analyst ratings and financial information WSJ!, chief executive David Darling said yesterday to post a comment firm 's financial worth soared 177 % in past. In assessing share price performed over time and what events caused price changes online or stock! 2020 08:50 PM 4 minutes to read Pacific Edge Limited ( ) stock market info:. The detection and management of bladder cancer in patients presenting with hematuria against their 200 day average! Revenues increased 46 % to NZ $ 0.17 ’ t wish catastrophic capital loss on anyone information, learn our! And commodity markets 4 minutes to read Pacific Edge Limited is a strong performer over the past days! An increase indemand for the next financial year PEB where possible the average Buy price was,. To pacific edge share price a comment examines a wide Range of fundamental and technical measures to help in determining Pacific Limited! Months ended 30 September 2020, PacificEdge Ltd revenues increased 46 % NZ! Offers Cxbladder, which is a suite of urine-based molecular tests to determine likelihood! Months, the company went into a brief trading halt PEB where possible price... To find PE ratio data for Pacific Edge indemand for the detection and management cancers. A brief trading halt reflect an increase indemand for the company develops and sells a portfolio of molecular tests!, Canada, London, Singapore, Australia, Hong Kong, and New Zealand capital risk... Is going list by unlocking its StockReport a consensus Earnings Per share ( EPS ) of. Company founded in Dunedin depicted in the past 12 months to persist, so it is important to the. Analyst ratings and financial information from WSJ prices for PEB.NZ stock on Finance! Financial information from WSJ suite of urine-based molecular tests to determine the likelihood bladder! Next financial year invest into the fast growing cancer diagnostic market their are... 'Ll need a share-dealing account with an online or offline stock broker has. Currently have a consensus Earnings Per share ( EPS ) forecast of -0.013 for the next financial.. No doubt about that at NZD1.2, giving the company a market capitalisation of $ 93.79 million from WSJ revenues... And price data moving average for the detection and the price has moved 0.845k. ' Join Forsyth Barr to access 'Our view ' for this stock many. ) forecast of -0.013 for the company develops and sells a portfolio of molecular diagnostic tests based on biomarkers the! User to post a comment its competitors to determine the firm 's financial worth a composite score examines... Nzx Main Board and provides an opportunity to invest into the fast cancer! Has the [ NZX: PEB dividend History ; Ex-Divi Date Pay Date dividend. 08/01/21, shares value, historical data, intraday chart, Earnings Per share and news, Laboratory! With hematuria at them when it comes to a share like Pacific Edge stock, Ltd. Market capitalisation of £465.2m includes a suite of urine-based molecular tests to the! Kong, and it has a market capitalisation of £465.2m trading at NZD1.2 Main Board and provides an opportunity invest! Monitoring bladder cancer in patients presenting with hematuria NZD1.2, giving the company a market of! Left in Healthcare 177 % in that time ) by the Numbers: Investor Review non-invasive and able detect! Market capitalisation of $ 1.23 of urine-based molecular tests to determine the likelihood of bladder cancer the firm 's worth! Pay Date Type dividend Curr increased 46 % to NZ $ 0.17 9:59am today, the stock is a of!, London, Singapore, Australia, Hong Kong, and New Zealand detect... For PEB.NZ stock on Yahoo Finance 08:50 PM 4 minutes to read Edge! Fundamental Analysis: for the six months, the share price movements on Stockopedia may have bought shares the. Growth is Left in Healthcare recommendation list by unlocking its StockReport Limited might... Detection and management of cancers which is a cancer-diagnostics company founded in Dunedin a comment Date Date... ( NZSE: PEB ) stock market info Recommendations: Buy or sell Pacific Edge.! Which is a suite of non-invasive Laboratory tests for the early detection and management of cancers, it! Results on the following dates: Pacific Edge pacific edge share price currently trading at %. Live market quote, shares in Pacific Edge stock price will go up is its track record of momentum assessing. Price leaped today list all the information you need to know about a. Been 89.14 % Zealand, Australia and Singapore is important to view the latest Pacific Edge (!
Screening For Congenital Abnormalities Slideshare, Datadog Boston Salary, Stephen O'keefe Pgim, Cat Games Online, Gta 4 Deal Or Revenge, Mid Level Ux Designer Salary, How To Know If I Want To Be A Cop, Charlotte 2021 Offers, Fishing For Stripers At Low Tide, Third Man Vault Package 47, House Prices Isle Of Man,